|
JPH0739379B2
(ja)
|
1988-12-28 |
1995-05-01 |
クリンゲ・ファルマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
トランス‐１，１，２‐トリフェニル―ブト‐１‐エン誘導体の製造方法
|
|
AU2004220321B2
(en)
|
2003-03-12 |
2010-02-25 |
Kudos Pharmaceuticals Ltd |
Phthalazinone derivatives
|
|
WO2005028436A2
(en)
|
2003-09-17 |
2005-03-31 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Thalidomide analogs as tnf-alpha modulators
|
|
PL1794163T3
(pl)
|
2004-09-22 |
2010-06-30 |
Pfizer |
Sposób wytwarzania inhibitorów poli(adp-rybozo)polimerazy
|
|
EA016079B1
(ru)
|
2007-01-10 |
2012-01-30 |
Институто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа |
Амидзамещенные индазолы в качестве ингибиторов поли(adp-рибоза)полимеразы (parp)
|
|
AU2008229383B2
(en)
|
2007-03-20 |
2013-09-05 |
Celgene Corporation |
4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
|
|
TWI389893B
(zh)
|
2007-07-06 |
2013-03-21 |
Astellas Pharma Inc |
二（芳胺基）芳基化合物
|
|
RU2472797C2
(ru)
|
2007-08-08 |
2013-01-20 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
ПРОИЗВОДНЫЕ 2-[(2-(ФЕНИЛАМИНО)-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА
|
|
EP2300013B2
(en)
|
2008-05-21 |
2024-11-13 |
Takeda Pharmaceutical Company Limited |
Phosphorous derivatives as kinase inhibitors
|
|
ES2668775T3
(es)
|
2009-06-10 |
2018-05-22 |
Chugai Seiyaku Kabushiki Kaisha |
Compuestos tetracíclicos
|
|
SG10201501062SA
(en)
|
2010-02-11 |
2015-04-29 |
Celgene Corp |
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
|
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
|
US9126947B2
(en)
|
2010-10-08 |
2015-09-08 |
Xcovery Holding Company Llc |
Substituted pyridazine carboxamide compounds
|
|
US8927725B2
(en)
*
|
2011-12-02 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Thio compounds
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
CN103396397A
(zh)
|
2013-08-14 |
2013-11-20 |
中国人民解放军军事医学科学院毒物药物研究所 |
来那度胺衍生物及其作为药物的用途
|
|
CN103787802B
(zh)
*
|
2014-02-11 |
2015-08-19 |
华东师范大学 |
一类芳基烷基硫醚化合物及其合成方法
|
|
CN119591582A
(zh)
|
2014-04-14 |
2025-03-11 |
阿尔维纳斯运营股份有限公司 |
基于酰亚胺的蛋白水解调节剂和相关使用方法
|
|
US20160022642A1
(en)
|
2014-07-25 |
2016-01-28 |
Yale University |
Compounds Useful for Promoting Protein Degradation and Methods Using Same
|
|
US10034872B2
(en)
*
|
2014-08-22 |
2018-07-31 |
Celgene Corporation |
Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
|
|
ES2901509T3
(es)
|
2014-10-30 |
2022-03-22 |
Kangpu Biopharmaceuticals Ltd |
Derivado de isoindolina, compuesto intermedio, métodos de preparación, composición farmacéutica y uso del mismo
|
|
KR20240119196A
(ko)
|
2015-06-04 |
2024-08-06 |
아비나스 오퍼레이션스, 인코포레이티드 |
단백질분해의 이미드계 조절인자 및 관련된 이용 방법
|
|
AU2016349781A1
(en)
|
2015-11-02 |
2018-05-10 |
Yale University |
Proteolysis targeting chimera compounds and methods of preparing and using same
|
|
WO2017117474A1
(en)
|
2015-12-30 |
2017-07-06 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional compounds for her3 degradation and methods of use
|
|
AU2017246453A1
(en)
|
2016-04-06 |
2018-11-08 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
JP7037500B2
(ja)
|
2016-04-06 |
2022-03-16 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｍｄｍ２タンパク質分解剤
|
|
EP3892272B1
(en)
|
2016-04-22 |
2024-07-24 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional molecules for degradation of egfr and methods of use
|
|
WO2017185031A1
(en)
|
2016-04-22 |
2017-10-26 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of use
|
|
EP3455219A4
(en)
|
2016-05-10 |
2019-12-18 |
C4 Therapeutics, Inc. |
AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
|
|
WO2017197056A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
CN106432104A
(zh)
|
2016-05-16 |
2017-02-22 |
大连医科大学 |
金刚烷基喹唑啉化合物、组合物及其用途
|
|
ES2857743T3
(es)
|
2016-09-13 |
2021-09-29 |
Univ Michigan Regents |
1,4-diazepinas fusionadas como degradadores de proteína BET
|
|
CN110062759B
(zh)
|
2016-09-13 |
2022-05-24 |
密执安大学评议会 |
作为bet蛋白降解剂的稠合的1,4-氧氮杂䓬
|
|
LT3660004T
(lt)
|
2016-10-11 |
2023-06-12 |
Arvinas Operations, Inc. |
Junginiai ir metodai, skirti tikslinei androgeno receptoriaus degradacijai
|
|
EP3535265A4
(en)
|
2016-11-01 |
2020-07-08 |
Arvinas, Inc. |
PROTACS TARGETING ON TAU PROTEIN AND RELATED METHODS FOR USE
|
|
US10925967B2
(en)
|
2016-11-22 |
2021-02-23 |
Dana-Farber Cancer Institute, Inc. |
Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use
|
|
WO2018102725A1
(en)
|
2016-12-01 |
2018-06-07 |
Arvinas, Inc. |
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
|
|
RU2019121527A
(ru)
|
2016-12-23 |
2021-01-15 |
Эрвинэс Оперейшнс, Инк. |
Химерные молекулы, нацеливающиеся на протеолиз egfr, и связанные с ними способы применения
|
|
EP3558994A4
(en)
|
2016-12-23 |
2021-05-12 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FAST ACCELERATED FIBROSARCOMA POLYPEPTIDES
|
|
MX2019008934A
(es)
|
2017-01-26 |
2019-11-05 |
Arvinas Operations Inc |
Moduladores de la proteolisis del receptor de estrogeno y métodos asociados de uso,.
|
|
TWI793151B
(zh)
|
2017-08-23 |
2023-02-21 |
瑞士商諾華公司 |
3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
|
|
KR20200086278A
(ko)
|
2017-10-18 |
2020-07-16 |
노파르티스 아게 |
선택적 단백질 분해를 위한 조성물 및 방법
|
|
EP3725771B1
(en)
|
2017-12-13 |
2026-02-04 |
Shanghaitech University |
Alk protein degradation agent and anti-tumor application thereof
|
|
IL315310A
(en)
|
2017-12-26 |
2024-10-01 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
CN119569702A
(zh)
|
2018-04-04 |
2025-03-07 |
阿尔维纳斯运营股份有限公司 |
蛋白水解调节剂及相关使用方法
|
|
US12226424B2
(en)
*
|
2018-04-09 |
2025-02-18 |
Shanghaitech University |
Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates
|
|
WO2020006264A1
(en)
|
2018-06-29 |
2020-01-02 |
Dana-Farber Cancer Institute, Inc. |
Ligands to cereblon (crbn)
|
|
US12459921B2
(en)
|
2018-09-30 |
2025-11-04 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Isoindoline compound, preparation method, pharmaceutical composition and use thereof
|
|
EP3896062A4
(en)
|
2018-12-06 |
2022-06-15 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
ISOINDOLINE COMPOUND, METHOD FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE OF ISOINDOLINE COMPOUND
|
|
US12582641B2
(en)
|
2019-02-25 |
2026-03-24 |
Shanghaitech University |
Sulfur-containing compound based on glutarimide skeleton and application thereof
|
|
CN109928956B
(zh)
|
2019-02-27 |
2020-10-13 |
杭州偶联医药科技有限公司 |
一种靶向泛素化降解egfr蛋白的化合物及其药物组合物和应用
|
|
AU2020248002A1
(en)
|
2019-03-26 |
2021-10-21 |
The Regents Of The University Of Michigan |
Small molecule degraders of STAT3
|
|
CN110204532B
(zh)
|
2019-05-15 |
2022-03-08 |
浙江工业大学 |
一种靶向egfr蛋白降解的化合物及其制备方法和应用
|
|
CN112321566B
(zh)
*
|
2019-08-05 |
2022-06-10 |
上海科技大学 |
Egfr蛋白降解剂及其抗肿瘤应用
|
|
CN110512980B
(zh)
|
2019-09-27 |
2024-08-30 |
苏州光格科技股份有限公司 |
一种防火门自动控制装置
|
|
MX2022006672A
(es)
|
2019-12-04 |
2022-08-08 |
Nurix Therapeutics Inc |
Compuestos bifuncionales para la degradacion de btk a traves de la via de proteosomas de ubiquitina.
|
|
EP4420728A3
(en)
|
2019-12-12 |
2024-10-30 |
Accutar Biotechnology Inc. |
Novel chroman derivatives having estrogen receptor degradation activity and uses thereof
|
|
CN113372327B
(zh)
*
|
2020-02-25 |
2023-07-18 |
上海科技大学 |
基于戊二酰亚胺骨架的化合物及其应用
|
|
CN113582980B
(zh)
*
|
2020-04-30 |
2023-11-24 |
上海科技大学 |
基于杂环和戊二酰亚胺骨架的化合物及其应用
|